Volume 1, Issue 8: Role of GLP-1 Receptor Agonists in the Treatment Continuum of Type 2 Diabetes-PODCAST
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 1, Issue 8)
Nurses and health care professionals involved in the care of patients with diabetes.
After participating in this activity, the participant will demonstrate the ability to:
- Explain why GLP-1 agonists should be considered early in the treatment of T2DM in obese patients.
- Discuss why GLP-1 agonists may be a better choice than basal insulin in selected obese patients with T2DM.
- Describe why adding GLP-1 agonist to a treatment regimen that already includes basal insulin may be better than adding nutritional insulin in obese patients with T2DM.
- 0.50 ANCC